Translational / Clinical Research

To make a difference in the development of cancer treatments, the basic knowledge must be translated and implemented in the clinic. Clinical hematology and oncology are where unanswered cancer-related questions and unmet clinical needs arise. Thus, a bi-directional flow of research from the laboratory bench to the patient’s bed and vice versa enables meaningful breakthroughs in cancer therapy.

Translational research is conducted in areas such as drug discovery, development, and delivery, and testing of alternative treatment modalities, culminating in clinical trails involving patients who take on personal risk for the benefit of society. In this regard, the Fishman Oncology Center, which is part of the RTICC’s translational arm and is located on our affiliated Rambam Health Care Campus, is a leader of the “first-in-human” approach and serves as a springboard for the accelerated implementation of new discoveries in the clinic, affecting the life of numerous hematology and oncology patients.